B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

OGG1

MOLECULAR TARGET

8-oxoguanine DNA glycosylase

UniProt: O15527NCBI Gene: 49682 compounds

OGG1 (8-oxoguanine DNA glycosylase) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OGG1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Isoniazid Antibacterial agent used primarily as1.102
2Aurintricarboxylic Acid0.691

About OGG1 as a Drug Target

OGG1 (8-oxoguanine DNA glycosylase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented OGG1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OGG1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.